ArticleCancer biology & therapy2024

Significant response to pembrolizumab plus lenvatinib in Epstein-Barr-virus-associated intrahepatic cholangiocarcinoma: a case report.

Lisha Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.